Enanta Pharmaceuticals Inc

NAS:ENTAHealthcareCBOEFTSE:MRUTNASDAQ:NBI

$11.41+2.79%At closeAt close · Tue 20 Oct · ≈ AED 41.90 · Market cap $332.32M · Next earnings Mon 16 Nov

Ratio	FY2020	FY2021	FY2022	FY2023	FY2024	FY2025	Current · undated	YoY
Gross margin	100.0%	100.0%	100.0%	100.0%	100.0%	93.0%	—	—
Operating margin	−34.0%	−112.9%	−143.7%	−173.2%	−179.9%	−130.7%	−130.7%	+0.0 pts
Net margin	−29.5%	−81.4%	−141.3%	−169.0%	−171.6%	−125.4%	−125.4%	+0.0 pts
EBITDA margin	−31.0%	−107.4%	−138.4%	−155.9%	−154.5%	−108.4%	—	—
Return on equity	−7.9%	−19.8%	−37.9%	−61.7%	−90.1%	−126.5%	−126.5%	+0.0 pts
Return on assets	−7.4%	−17.9%	−32.0%	−28.9%	−30.8%	−29.2%	−29.2%	+0.0 pts
Return on capital employed	−8.9%	−27.1%	−35.3%	−34.3%	−38.1%	−36.8%	—	—
Debt / equity	0.0×	0.0×	0.1×	0.1×	1.8×	3.1×	3.1×	+0.0%
Debt / assets	2.0%	1.6%	7.0%	5.7%	60.0%	71.6%	—	—
Interest coverage	0.0×	0.0×	0.0×	−26.7×	−11.1×	−11.1×	—	—
Current ratio	18.1×	8.8×	10.5×	6.7×	5.2×	4.2×	4.2×	+0.0%
Quick ratio	18.1×	8.8×	10.5×	6.7×	5.2×	4.2×	—	—
Cash ratio	3.6×	1.6×	1.5×	1.4×	0.6×	0.7×	0.7×	+0.0%
Asset turnover	0.2×	0.2×	0.2×	0.2×	0.2×	0.2×	—	—
Receivables turnover	5.2×	1.6×	1.8×	2.0×	1.8×	9.5×	—	—
Dividend payout	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%	—	—

Margins, returns, leverage and liquidityUpdated 30 Sep 2025 ·

ⓘ

Current snapshot ratios have no reporting date and are shown separately from fiscal periods.